Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Global marketing rights to Caelyx to transition from Merck & Co. to Janssen

Oct. 5, 2010

Dyax and CMIC partner in development and marketing of DX-88 for HAE in Japan

Oct. 4, 2010

Aveo Pharmaceuticals regains worldwide rights to AV-299

Oct. 4, 2010

Pieris, sanofi-aventis and Sanofi Pasteur to develop anticalin therapeutics

Oct. 1, 2010

Astellas and UMN Pharma enter definitive agreement for flu vaccines

Oct. 1, 2010

Dana-Farber Cancer Institute and sanofi-aventis collaborate on oncology targets

Sep. 30, 2010

RXi and EyeGate Pharma collaborate on ocular drug delivery system

Sep. 27, 2010

Pro-Pharmaceuticals and Numoda collaborate on phase III Davanat trial

Sep. 27, 2010

Topica announces sublicensing agreement for luliconazole for tinea infections

Sep. 23, 2010

Epitomics and Michael J. Fox Foundation collaborate on LRRK2 antibodies

Sep. 22, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...